Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs.
The anthracyclines, such as doxorubicin (DXR), are potent anti-cancer drugs but they are limited by their clinical toxicity. The mechanisms involved remain poorly understood partly because of the difficulty in determining sub-cellular drug localisation. Using a novel method utilising the fluorescent...
Auteurs principaux: | Ashley, N, Poulton, J |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2009
|
Documents similaires
-
Targeting DNA with Anthracyclines: The Importance of the Sugar Moiety
par: Waldemar Priebe
Publié: (2000-03-01) -
Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modelling.
par: Ashley, N, et autres
Publié: (2009) -
Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
par: Junqi Huang, et autres
Publié: (2022-02-01) -
Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer
par: Craig Davison, et autres
Publié: (2021-04-01) -
Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
par: Alessandra Murabito, et autres
Publié: (2020-03-01)